Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| Transverse Sinuses | D054064 | [The two large endothelium-lined venous channels that begin at the internal occipital protuberance at the back and lower part of the CRANIUM and travels laterally and forward ending in the internal jugular vein (JUGULAR VEINS). One of the transverse sinuses, usually the right one, is the continuation of the SUPERIOR SAGITTAL SINUS. The other transverse sinus is the continuation of the straight sinus.] |
| turmeric extract | C012596 | |
| uranium dioxide | C012597 | |
| Leukemia, Large Granular Lymphocytic | D054066 | [A spectrum of disorders characterized by clonal expansions of the peripheral blood LYMPHOCYTE populations known as large granular lymphocytes which contain abundant cytoplasm and azurophilic granules. Subtypes develop from either CD3-negative NATURAL KILLER CELLS or CD3-positive T-CELLS. The clinical course of both subtypes can vary from spontaneous regression to progressive, malignant disease.] |
| Leukemia, T-Cell | D015458 | [A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.] |
| pyriminil | C012598 | |
| Dihydropyrimidine Dehydrogenase Deficiency | D054067 | [An autosomal recessive disorder affecting DIHYDROPYRIMIDINE DEHYDROGENASE and causing familial pyrimidinemia. It is characterized by thymine-uraciluria in homozygous deficient patients. Even a partial deficiency in the enzyme leaves individuals at risk for developing severe 5-FLUOROURACIL-associated toxicity.] |
| Purine-Pyrimidine Metabolism, Inborn Errors | D011686 | [Dysfunctions in the metabolism of PURINES or PYRIMIDINES resulting from inborn genetic mutations that are inherited or acquired in utero.] |
| Autoimmune Lymphoproliferative Syndrome, Type IIA | C565833 | |
| Beta Thalassemia, Dominant Inclusion Body Type | C565834 | |
| Vanishing White Matter Leukodystrophy with Ovarian Failure | C565836 | |
| Nalp1 protein, rat | C526260 | |
| 17-hydroxy-7-fluoro-17-methylandrostan-3-one | C119480 | |
| Postthrombotic Syndrome | D054070 | [A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA; PAIN; aching; heaviness; and MUSCLE CRAMP in the leg. When severe leg swelling leads to skin breakdown, it is called venous STASIS ULCER.] |
| Venous Insufficiency | D014689 | [Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.] |
| Venous Thrombosis | D020246 | [The formation or presence of a blood clot (THROMBUS) within a vein.] |
| Nalp5 protein, rat | C526261 | |
| thiotyrosyl-glycyl-glycine | C119481 | |
| mbl-1 protein, C elegans | C526262 | |
| 5-amino-3-(4-chlorophenyl)pentanoic acid | C119482 |